Westfield Capital Management
CHRS icon

Westfield Capital Management’s Coherus Oncology CHRS Stock Holding History

Westfield Capital Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-778,041
Closed -$12.7M – 309
2014
Q4 		$12.7M Buy
+778,041
New +$11M 0.07% 227

Other funds holding CHRS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management's CHRS Position: Q1 2015 in Review

Westfield Capital Management sold out of Coherus Oncology (CHRS) in Q1 2015, closing a stake of 778,041 shares — an estimated $12.7M sold.

Westfield Capital Management first reported a position in CHRS in Q4 2014 and held it in 1 quarter. The position peaked at $12.7M in Q4 2014. 51 funds tracked by Wall St. Rank hold CHRS as of Q1 2015.

  • Westfield Capital Management reported no remaining Coherus Oncology position as of Q1 2015 after selling out during the quarter.
  • Westfield Capital Management sold 778,041 Coherus Oncology shares in Q1 2015, an estimated $12.7M.
  • Westfield Capital Management first reported a position in Coherus Oncology in Q4 2014 and held it in 1 quarter.
  • Westfield Capital Management's Coherus Oncology position peaked at $12.7M in Q4 2014.
  • 51 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2015.

Based on Westfield Capital Management's 13F filing for Q1 2015, filed 13 May 2015.